Atherosclerosis and Hyperlipidemia

ACC.24: Olezarsen for Hypertriglyceridemia and ASCVD

Brian Bergmark,

Watch time: 3m 40s
ACC.24: The LIBerate-CVD Trial

Evan A Stein,

Watch time: 7m 18s

Nicolas M Van Mieghem, Joost Daemen,

Watch time: 1h 35m 42s (16 videos)
ESC 23: LIBerate-HeFH Study

Frederick Raal,

Watch time: 4m 16s
ESC 23: OCEAN(a)-DOSE Trial Update

Michelle O'Donoghue,

Watch time: 3m 22s

Joost Daemen, Allen Jeremias, Ziad A Ali, et al

Watch time: 55m 46s (1 video)

Marinela Beznă , Gabriela Mitoaica , Lorena Ungureanu , et al

Read time: 1 Min
Dietary Sodium Intake and Atherosclerosis

Jonas Wuopio,

Watch time: 3m 1s
ACC 23: Lipid Management & the CLEAR Trial with Dr Michos

Erin D Michos,

Watch time: 5m 34s
View from the Thoraxcenter: ACC.23 Late-breaking Science Wrap Up

Nicolas M Van Mieghem, Joost Daemen,

Watch time: 33m 36s
ACC 23: MK-0616: Oral PCSK9 inhibitor In Hypercholesterolemia Patients

Christie Ballantyne,

Watch time: 3m 44s
ACC 23: Effect of Evolocumab on Coronary Plaque Morphology: The YELLOW III Study

Annapoorna Kini ,

Watch time: 8m 1s

Hans-Willi Breuer ,

Ewa Dembowski , Michael H Davidson ,

Sumanth Khadke , Jovana Vidovic , Vinod Patel ,

Alberto Lorenzatti , Peter P Toth ,

Kausik Ray, , , et al

Watch time: 1h 35m (4 videos)

Kerry Layne , Albert Ferro ,

Maciej Banach, Yassir Javaid, Lale Tokgözoğlu, et al

Watch time: 1h 27m 1s

Yassir Javaid, , , et al

Watch time: 18m 47s (4 videos)

Cameron T Lambert , Pratik Sandesara , Ijeoma Isiadinso , et al

Iana Simova ,

Reynaria N Pitts , Robert Eckel ,

Kazeen Abdullah , Anand Rohatgi ,

Read time: 18m

Media

Nicolas M Van Mieghem, Joost Daemen,

Watch time: 1h 35m 42s (16 videos)

Joost Daemen, Allen Jeremias, Ziad A Ali, et al

Watch time: 55m 46s (1 video)
ACC 23: Effect of Evolocumab on Coronary Plaque Morphology: The YELLOW III Study

Annapoorna Kini ,

Watch time: 8m 1s
ACC.23 Late-Breaker Discussion: The CLEAR-Outcomes Trial

Harriette Van Spall, Steven E Nissen,

Watch time: 16m 12s
View from the Thoraxcenter: What's Hot at ACC.23?

Nicolas M Van Mieghem, Joost Daemen,

Watch time: 22m 4s
Radcliffe & CardioNerds @AHA22: Reduction of Lp(a) With Small Interfering RNA

Gurleen Kaur, Michelle O'Donoghue,

Watch time: 14m 28s
Radcliffe & CardioNerds @AHA22: Reduction of Triglycerides With Pemafibrate

Aruna D Pradhan, Gurleen Kaur,

Watch time: 14m 20s

Yassir Javaid, , , et al

Watch time: 18m 47s (4 videos)

Maciej Banach, Yassir Javaid, Lale Tokgözoğlu, et al

Watch time: 1h 27m 1s

Media

ACC.24: The LIBerate-CVD Trial

Evan A Stein,

Watch time: 7m 18s
ACC.24: Olezarsen for Hypertriglyceridemia and ASCVD

Brian Bergmark,

Watch time: 3m 40s

Joost Daemen, Allen Jeremias, Ziad A Ali, et al

Watch time: 55m 46s (1 video)

Yassir Javaid, , , et al

Watch time: 18m 47s (4 videos)
ACC 23: MK-0616: Oral PCSK9 inhibitor In Hypercholesterolemia Patients

Christie Ballantyne,

Watch time: 3m 44s
ACC 23: Effect of Evolocumab on Coronary Plaque Morphology: The YELLOW III Study

Annapoorna Kini ,

Watch time: 8m 1s
ACC.23 Late-Breaker Discussion: The CLEAR-Outcomes Trial

Harriette Van Spall, Steven E Nissen,

Watch time: 16m 12s
ESC 23: OCEAN(a)-DOSE Trial Update

Michelle O'Donoghue,

Watch time: 3m 22s
ESC 23: LIBerate-HeFH Study

Frederick Raal,

Watch time: 4m 16s

Nicolas M Van Mieghem, Joost Daemen,

Watch time: 1h 35m 42s (16 videos)

Maciej Banach, Yassir Javaid, Lale Tokgözoğlu, et al

Watch time: 1h 27m 1s
Radcliffe & CardioNerds @AHA22: Reduction of Triglycerides With Pemafibrate

Aruna D Pradhan, Gurleen Kaur,

Watch time: 14m 20s

Articles

A Review of Angiotensin Receptor Blocker-based Therapies at all Levels of Cardiovascular Risk

Giuliano Tocci

,

Lorenzo Castello

,

Massimo Volpe

,

Citation:

European Cardiology 2011;7(4):254–6

DOI:

https://doi.org/10.15420/ecr.2011.7.4.254
Permissions× For commercial reprint enquiries please contact Springer Healthcare: ReprintsWarehouse@springernature.com.

For permissions and non-commercial reprint enquiries, please visit Copyright.com to start a request.

For author reprints, please email rob.barclay@radcliffe-group.com.
  • Views: Views 862
  • Downloads: Downloads 7
  • Citations: 1

Adherence to Antihypertensive and Lipid-lowering Therapy - Impact on Clinical Practice

Leif Erhardt

,

Jean-Jacques Mourad

,

Citation:

European Cardiology 2008;4(2):10–5

DOI:

https://doi.org/10.15420/ecr.2008.4.2.10
Permissions× For commercial reprint enquiries please contact Springer Healthcare: ReprintsWarehouse@springernature.com.

For permissions and non-commercial reprint enquiries, please visit Copyright.com to start a request.

For author reprints, please email rob.barclay@radcliffe-group.com.
  • Views: Views 1310
  • Downloads: Downloads 21
  • Citations: 4

Circulating Endothelial Progenitor Cells - Characterisation, Function and Relationship with Cardiovascular Risk Factors

Alberto Balbarini

,

Rossella Di Stefano

,

Citation:

European Cardiology 2008;4(2):16–9

DOI:

https://doi.org/10.15420/ecr.2008.4.2.16
Permissions× For commercial reprint enquiries please contact Springer Healthcare: ReprintsWarehouse@springernature.com.

For permissions and non-commercial reprint enquiries, please visit Copyright.com to start a request.

For author reprints, please email rob.barclay@radcliffe-group.com.
  • Views: Views 904
  • Downloads: Downloads 0
  • Citations: 4

Time to Act - Guideline-defined Treatment Goals for Cardiovascular Risk Factors Are Not Achieved in Primary Care

J Christoph Geller

,

Citation:

European Cardiology 2008:4(2):24-6

DOI:

https://doi.org/10.15420/ecr.2008.4.2.24
Permissions× For commercial reprint enquiries please contact Springer Healthcare: ReprintsWarehouse@springernature.com.

For permissions and non-commercial reprint enquiries, please visit Copyright.com to start a request.

For author reprints, please email rob.barclay@radcliffe-group.com.
  • Views: Views 689
  • Downloads: Downloads 6
  • Citations: 1